Quick search:
Result | Content | Outlet | Published | Research |
---|---|---|---|---|
Result | Content | Outlet | Published | Research |
1 | FDA Roundup: May 24, 2022 | FDA | FDA.gov | 23 hours ago | |
2 | FDA Roundup: May 20, 2022 | FDA | FDA.gov | 5 days ago | |
3 | Dermavent nabs its first FDA approval | FiercePharma | 15 hours ago | |
4 | FDA Flexibilities to Yield Millions of Cans of Additional Infant Formula in Coming Months to Increase Supply Available to US Consumers | FDA | FDA.gov | 23 hours ago | |
5 | FDA Roundup: May 10, 2022 | FDA | FDA.gov | 15 days ago | |
6 | FDA Provides New Updates on Activities to Mitigate Infant Formula Supply Challenges, Abbott Nutrition Agrees to Take Corrective Actions at Facility to Produce Safe Infant Formula | FDA | FDA.gov | 9 days ago | |
7 | FDA Takes Important Steps to Improve Supply of Infant and Specialty Formula Products | FDA | FDA.gov | 15 days ago | |
8 | FDA Approves First Treatment for Eosinophilic Esophagitis, a Chronic Immune Disorder | FDA | FDA.gov | 4 days ago | |
9 | Pharma company continues its FDA lawsuit spree, this time after agency denies fast-track designation | Endpoints News | 9 hours ago | |
10 | FDA Approves Novel, Dual-Targeted Treatment for Type 2 Diabetes | FDA | FDA.gov | 12 days ago | |
11 | United scores FDA approval for inhaled Tyvaso | FiercePharma | 14 hours ago | |
12 | FDA Roundup: May 3, 2022 | FDA | FDA.gov | 22 days ago | |
13 | FDA accepts CSL Behring's gene therapy for speedy review | FierceBiotech | 12 hours ago | |
14 | U.S. FDA allows importing of 2 mln baby formula cans from UK | Reuters.com | 4 hours ago | |
15 | Pfizer spinout SpringWorks will ship its first drug to the FDA before year's end with PhIII win | Endpoints News | 14 hours ago | |
16 | Know Labs builds exec team ahead of FDA diabetes submission | FierceBiotech | 10 hours ago | |
17 | D-tagatose Added Sugar Classification Exemption Denied by FDA | The National Law Review | 7 hours ago | |
18 | FDA warns against storing avocados in water as seen in viral social media hack | ABC News | 7 hours ago | |
19 | Why This FDA Approval Is a Game Changer for Eli Lilly | The Motley Fool | 12 hours ago | |
20 | FDA Roundup: May 13, 2022 | FDA | FDA.gov | 12 days ago | |
21 | The FDA says it's in the dark about thousands of dietary supplement ingredients | STAT | 18 hours ago | |
22 | Cargill Voluntarily Recalls 795, 8oz Boxes of Product Containing Jif® Peanut Butter Due to the Potential for Salmonella Contamination | FDA.gov | 1 day ago | |
23 | Asia-Pacific Roundup: Philippine FDA seeks feedback on abridged procedures for clinical trial applications | Regulatory Focus | 10 hours ago | |
24 | FDA Roundup: May 6, 2022 | FDA | FDA.gov | 19 days ago | |
25 | AbbVie adds to Vraylar data as FDA considers depression use | - pharmaphorum | 17 hours ago | |
26 | Mitt Romney pummels House bill to help FDA fix baby formula shortage | Business Insider | 6 hours ago | |
27 | Congress Moves to Protect FDA Orphan Drug Act Upset in LEMS Ruling | Lambert-Eaton News | 11 hours ago | |
28 | FDA Roundup: April 29, 2022 | FDA | FDA.gov | 26 days ago | |
29 | FDA: 124 Suspected Deaths Tied to Recalled Sleep Aid Devices | NBC Chicago | 1 day ago | |
30 | FDA Issues Warning Letters to Companies Illegally Selling CBD and Delta-8 THC Products | FDA | FDA.gov | 21 days ago | |
31 | Coronavirus (COVID-19) Update: FDA Authorizes First COVID-19 Test Available without a Prescription That Also Detects Flu and RSV | FDA | FDA.gov | 9 days ago | |
32 | FDA Updates on Paxlovid for Health Care Providers | FDA | FDA.gov | 21 days ago | |
33 | Magnolia Medical Announces Successful FDA Field Inspection Results and Formal Warning Letter Close-Out | PR Newswire | 10 hours ago | |
34 | FDA Urges Drug Manufacturers to Develop Risk Management Plans to Promote a Stronger, Resilient Drug Supply Chain | FDA | FDA.gov | 6 days ago | |
35 | FDA to discuss COVID-19 vaccination for infants, toddlers | SILive.com | 1 day ago | |
36 | Coronavirus (COVID-19) Update: FDA Expands Eligibility for Pfizer-BioNTech COVID-19 Vaccine Booster Dose to Children 5 through 11 Years | FDA | FDA.gov | 8 days ago | |
37 | US dairy industry hits out as FDA issues a stay on yogurt rules | DairyReporter.com | 18 hours ago | |
38 | Nymox slumps as FDA rejects filing for prostate drug | - pharmaphorum | 14 hours ago | |
39 | FDA clears RapidAI's pulmonary embolism triage platform | Mass Device | 10 hours ago | |
40 | FDA Issues Labeling Guidance | Pharmaceutical Technology Magazine | 1 day ago | |
41 | inHeart wins FDA clearance for 3D cardiac modeling software | Mass Device | 12 hours ago | |
42 | Coronavirus (COVID-19) Update: FDA Approves First COVID-19 Treatment for Young Children | FDA | FDA.gov | 30 days ago | |
43 | Why Is the FDA Seizing Baby Formula During a Baby Formula Shortage? | The Wall Street Journal | 2 days ago | |
44 | Alpine Immune Sciences Announces FDA Removes Partial Clinical Hold on NEON-2 Clinical Trial of Davoceticept (ALPN-202) in Combination with Pembrolizumab | Yahoo Finance | 15 hours ago | |
45 | FDA will review vibrating constipation pill from Vibrant Gastro | FierceBiotech | 2 days ago | |
46 | The FDA’s rejection of fluvoxamine as a Covid drug, explained | Vox.com | 5 days ago | |
47 | Fostering Medical Device Improvement: FDA Activities and Engagement with the Voluntary Improvement Program | FDA | FDA.gov | 20 days ago | |
48 | FDA calls for noninferiority trials for antibacterials, thanks to new drugs for resistant infections | Endpoints News | 1 day ago | |
49 | Coronavirus (COVID-19) Update: FDA Limits Use of Janssen COVID-19 Vaccine to Certain Individuals | FDA | FDA.gov | 20 days ago | |
50 | Verrica Receives Complete Response Letter from the FDA for its NDA for VP-102 as a Direct ... | El Paso Inc. | 3 hours ago | |
51 | Congress Presses FDA on Key Policies and Operations | Pharmaceutical Executive | 21 days ago | |
52 | FDA Takes Steps to Limit Lead in Juice to Further Reduce Exposure to Toxic Elements in Foods | FDA | FDA.gov | 28 days ago | |
53 | Today in Capital Matters: FDA and Diesel | National Review | 12 hours ago | |
54 | FDA to Review Intranasal Zavegepant for Migraine Treatment | Monthly Prescribing Reference | 12 hours ago | |
55 | From Our Perspective: FDA's Role in Helping a Critical Medical Isotope Meet Sufficient Supply in the US for First Time | FDA | FDA.gov | 14 days ago | |
56 | AbbVie Files for FDA Approval of ABBV-951 Levodopa Infusion | Parkinson's News Today | 15 hours ago | |
57 | Covaxin Clinical Trials To Resume In The Us As Fda Lifts Halt | Mint | Mint | 14 hours ago | |
58 | CDER Launches New Accelerating Rare disease Cures (ARC) Program | FDA.gov | 15 days ago | |
59 | INmune Bio Shares Hit 52-Week Low After FDA Requests More Data on XPro1595 | MarketWatch | 10 hours ago | |
60 | FDA OKs Use of Drug Viloxazine for ADHD in Adults | Healthline | 1 day ago | |
61 | FDA Grants Breakthrough Device Designation to Anumana's ECG Pulmonary Hypertension Early Detection AI Algorithm | BioSpace | 15 hours ago | |
62 | FDA Approves Oral Form for the treatment of adults with amyotrophic lateral sclerosis (ALS) | FDA | FDA.gov | 13 days ago | |
63 | Coronavirus (COVID-19) Update: FDA Announces Tentative Advisory Committee Meeting Schedule Regarding COVID- 19 Vaccines | FDA | FDA.gov | 26 days ago | |
64 | Study: Blockbuster, accelerated approval drugs more likely to get new FDA-approved formulation | Regulatory Focus | 1 day ago | |
65 | Surprise US FDA Facility Inspections Resume In India | Pink Sheet | 6 hours ago | |
66 | FDA announces recall of platelet-reducing medication due to risk of clotting or other adverse cardiovascular outcomes | Cardiovascular Business | 10 hours ago | |
67 | FDA Accepts BLA of Mirvetuximab Soravtansine Under Priority Review in FRα-high Platinum-Resistant Ovarian Cancer | Cancer Network | 1 day ago | |
68 | WHO: Monkeypox Containable; FDA Sets Date for Toddler Vax Debate; COVID Organ Damage | Medpage Today | 14 hours ago | |
69 | FDA Permits Marketing for New Test to Improve Diagnosis of Alzheimer's Disease | FDA | FDA.gov | 21 days ago | |
70 | Xcovery SHP2 Inhibitor IND Approved by US FDA | Business Wire | 1 day ago | |
71 | ENB Therapeutics Announces Orphan Drug Designation Granted by FDA for ENB-003 for the Treatment of Pancreatic Cancer | BioSpace | 15 hours ago | |
72 | Do Not Use Skippack Medical Lab SARS-CoV-2 Antigen Rapid Test | FDA.gov | 15 days ago | |
73 | FDA's Office of Compliance details enforcement actions in 2021 | Regulatory Focus | 23 days ago | |
74 | U.S. FDA declines to approve two more China-tested drugs | Reuters.com | 23 days ago | |
75 | Regulatory Education for Industry (REdI) Annual Conference 2022 | FDA.gov | 12 days ago | |
76 | FDA Proposes Rules Prohibiting Menthol Cigarettes and Flavored Cigars to Prevent Youth Initiation, Significantly Reduce Tobacco-Related Disease and Death | FDA | FDA.gov | 27 days ago | |
77 | FDA to study how patients, physicians choose prescription drugs | FiercePharma | 29 days ago | |
78 | F.D.A. Authorizes Underwear to Protect Against S.T.I.s During Oral Sex | The New York Times | 13 days ago | |
79 | Mars Wrigley Confectionery US, LLC Issues Voluntary Recall of Specific Varieties of SKITTLES® Gummies, STARBURST® Gummies, and LIFE SAVERS® Gummies Due to Potential Presence of Thin Metal Strand Embedded in Gummies or Loose in the Bag | FDA.gov | 12 days ago | |
80 | FDA commissioner announces new role for Janet Woodcock, downshifting away from drugs | Endpoints News | 4 hours ago | |
81 | Novavax confident Covid vaccine will receive FDA authorization in June after delays | CNBC | 12 days ago | |
82 | Will the FDA change how it vets drugs following the Alzheimer's debacle? | Nature.com | 12 days ago | |
83 | FDA officials say annual Covid-19 shots may be needed in the future | CNN | 22 days ago | |
84 | Strauss Israel Announces Voluntary Recall of Certain Confectionery Products Because of Possible Health Risk | FDA.gov | 27 days ago | |
85 | Moderna seeks FDA authorization for vaccine for very young : Shots | Health News | 27 days ago | |
86 | AFDO Urges FDA to Change Food Recall Activities | The National Law Review | 29 days ago | |
87 | HP Hood LLC Issues Allergy Alert on Undeclared Peanuts in Planet Oat Non-Dairy Frozen Dessert (Updated: Additional Locations) | FDA.gov | 13 days ago | |
88 | Dymski Pierogies DBA Grandma's Cuisine Issues Allergy Alert on Undeclared Milk in Frozen Cheese Filled Pierogis | FDA.gov | 19 days ago | |
89 | AstraZeneca, GSK's cancer rival Clovis quietly unveils crippling FDA delay as its troubles deepen | FiercePharma | 19 days ago | |
90 | Misinformation spurring US life expectancy "erosion," FDA chief says | Axios | 18 days ago | |
91 | Whistleblower warned FDA about formula plant months before baby deaths | POLITICO | 27 days ago | |
92 | FDA authorizes revisions to Evusheld dosing | FDA | FDA.gov | 3 months ago | |
93 | FDA updates Sotrovimab emergency use authorization | FDA | FDA.gov | 2 months ago | |
94 | FDA Roundup: February 4, 2022 | FDA | FDA.gov | 4 months ago | |
95 | FDA Roundup: March 29, 2022 | FDA | FDA.gov | 2 months ago | |
96 | FDA Alerts the Public to Potentially Contaminated Products from Family Dollar Stores in Six States | FDA | FDA.gov | 3 months ago | |
97 | FDA Roundup: April 1, 2022 | FDA | FDA.gov | 2 months ago | |
98 | FDA Roundup: March 11, 2022 | FDA | FDA.gov | 2 months ago | |
99 | FDA Seeks $8.4 Billion to Further Investments in Critical Public Health Modernization, Core Food and Medical Product Safety Programs | FDA | FDA.gov | 2 months ago | |
100 | Coronavirus (COVID-19) Update: FDA Takes Key Action by Approving Second COVID-19 Vaccine | FDA | FDA.gov | 4 months ago |